Colorado Therapeutics' Unattributed - III Round

Colorado Therapeutics raised a round of funding on January 26, 2018.

Colorado Therapeutics is focused on developing xenogenic (sourced from different mammalian species) biologic tissue matrix products for a broad range of soft tissue reinforcement, regenerative, and va…

Articles about Colorado Therapeutics' Unattributed - III Round: